Shows / Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Episodes
Decera Clinical Education Oncology PodcastNew Evidence With BTK Inhibitor Therapy in CLL From EHA 2023
In this episode, Catherine C. Coombs, MD, MS, and Toby Eyre, MBChB, MD, discuss key trials presented at EHA 2023 evaluating the use of BTK inhibitors in…
Decera Clinical Education Oncology PodcastExpert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
In this episode, Kathleen Moore, MD, MS, and Nicoletta Colombo, MD, PhD, provide expert insights on key updates and new clinical trial data presented at the…
Decera Clinical Education Oncology PodcastExpert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
In this episode, David Scott Miller, MD, FACOG, FACS, and Linda Duska, MD, MPH, provide expert insights on practice-changing data and other new findings…
Decera Clinical Education Oncology PodcastPractical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma
In this episode, Suzanne Lentzsch, MD, Ph.D., and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of BCMA-targeted therapies in the management of…
Decera Clinical Education Oncology PodcastContemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts
In this episode, John Mascarenhas, MD, and Ruben A. Mesa, MD, FACP, discuss current best practices and emerging approaches for treating patients with…
Decera Clinical Education Oncology PodcastBRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges
In this episode, Banu Arun, MD; Allison Butts, PharmD, BCOP; and Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP, discuss the role of BRCA testing and adjuvant…
Decera Clinical Education Oncology PodcastExperts Discuss Claudin 18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers
In this podcast episode, Samuel Klempner, MD, and Gregory Botta, MD, PhD, provide expert commentary on the rationale and development of novel agents under…
Decera Clinical Education Oncology PodcastTreatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts
In this podcast episode, Prithviraj Bose, MD, and Andrew Kuykendall, MD, discuss their contemporary approaches to the treatment of patients with essential…
Decera Clinical Education Oncology PodcastFAQs on the Use of Asparaginase Therapy in Young and Older Adults With Acute Lymphoblastic Leukemia
In this episode, Daniel J. DeAngelo, MD, PhD; Kjeld Schmiegelow, MD, DMSci; and Emily Curran, MD, answer key questions asked by the audience during a live…
Decera Clinical Education Oncology PodcastExperts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes
In this podcast, Rami Komrokji, MD; María Díez Campelo, MD, PhD; and Amer Zeidan, MBBS, MHS answer questions from an audience of healthcare professionals on…
Decera Clinical Education Oncology PodcastExperts Answer Questions on the Management of Patients With T-Cell Lymphomas
In this podcast episode, Steven M. Horwitz, MD; Pamela B. Allen, MD, MSc; and Kerry Savage, MD, MSc, answer questions from an audience of healthcare…
Decera Clinical Education Oncology PodcastIndividualizing Care for Patients With Triple-Negative Breast Cancer
In this podcast episode from a live CCO Cancer Conversations webinar, Mark Pegram, MD, and Sara Tolaney, MD, MPH, provide expert perspectives on optimal…
Decera Clinical Education Oncology PodcastContemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts
In this podcast episode, Raajit Rampal, MD, PhD, and Brady L. Stein, MD, MHS, discuss their contemporary approaches to the treatment of patients with…
Decera Clinical Education Oncology PodcastHCC Surveillance: Challenges and Opportunities
In this episode, David Kaplan, MD, MSc, and Tamar Taddei, MD, discuss which patients should be screened for hepatocellular carcinoma, current surveillance…
Decera Clinical Education Oncology PodcastA Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
In this episode, Zoe Lanham, a woman with high-risk hormone receptor–positive/HER2-negative early breast cancer, discusses the importance of effective…
Decera Clinical Education Oncology PodcastExpert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers
In this episode, Prof Isabelle Ray Coquard, MD, PhD, and Ignace Vergote, MD, PhD, share their thoughts on key studies of interested presented at the 2022 ESGO…
Decera Clinical Education Oncology PodcastThe Transgender Cancer Experience: A Conversation Between an Oncologist and a Transmasculine Individual on Navigating the Healthcare System
In this episode, activist and breast cancer survivor Yee Won Chong shares his experience as a transmasculine person navigating the healthcare system with Norma…
Decera Clinical Education Oncology PodcastEvolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions
In this episode, Farrukh T. Awan, MD, and Nicole Lamanna, MD, answer questions from an audience of healthcare professionals on topics related to the use of BTK…
Decera Clinical Education Oncology PodcastNew Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting
In this episode, Christopher R. Flowers, MD, MS, and Kami Maddocks, MD, discuss their choices of recent important trials presented at the Society of…
Decera Clinical Education Oncology PodcastExpert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting
In this episode,Susana Banerjee, MBBS, MA, PhD, and Mansoor Raza Mirza, MD, share their thoughts on key studies of interested presented at the IGCS 2022 Annual…
Decera Clinical Education Oncology PodcastRelapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape
In this podcast episode from Clinical Care Options, Paul G. Richardson, MD; Natalie S. Callander, MD; and Noopur Raje, MD, answer questions from a live webinar…
Decera Clinical Education Oncology PodcastExpert Insights on Key Updates From the 2022 ESMO Congress on PARP Inhibitors in Ovarian Cancer
In this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide their expert insights on key updates presented for ovarian cancer trials…
Decera Clinical Education Oncology PodcastManaging EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions
In this episode, Ryan D. Gentzler, MD, MS, and Jonathan Riess, MD, MS, answer audience questions on managing EGFR-mutated non-small-cell lung cancer (NSCLC)…
Decera Clinical Education Oncology PodcastNew Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022
In this episode, Julie M. Vose, MD, MBA, and Matthew S. Davids, MD, MMSc, discuss their choices of recent important trials presented at the Pan Pacific…
Decera Clinical Education Oncology PodcastExperts Discuss Challenges in Advanced Hepatocellular Carcinoma Management
In this podcast episode from Clinical Care Options (CCO), Heinz-Josef Klumpen, MD, PhD, and Chris Verslype, MD, PhD, discuss challenges in selecting and…
Decera Clinical Education Oncology PodcastHER2-Positive Breast Cancer: Current Approaches for Quality Care
In this episode, Erika P. Hamilton, MD, and Komal Jhaveri, MD, discuss their approaches to and key studies for current management of patients with…
Decera Clinical Education Oncology PodcastNew Evidence With BTK Inhibitor Therapy in CLL and MCL From EHA 2022
In this episode, Othman Al-Sawaf, MD, and Lydia Scarfò, MD, discuss key trials presented at EHA 2022 evaluating the use of BTK inhibitors in chronic…
Decera Clinical Education Oncology PodcastNew Evidence With BTK Inhibitor Therapy in CLL and MCL From ASCO 2022
In this episode, Brad S. Kahl, MD, and Anthony Mato, MD, MSCE, discuss their choices of 3 recent important trials presented at ASCO 2022 evaluating the use of…
Decera Clinical Education Oncology PodcastExpert Insights on New Data From ASCO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
In this episode, Jubilee Brown, MD, and Elisabeth Diver, MD, provide expert insights on new data presented at ASCO 2022 for ovarian, endometrial, and cervical…
Decera Clinical Education Oncology PodcastExpert Insight on Key Data From SGO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
In this episode, David Scott Miller, MD, FACOG, FACS, and Angeles Alvarez Secord, MD, MHSc, provide expert insights on key data presented at SGO 2022 for…
Decera Clinical Education Oncology PodcastCall to Action and Reflection: Inclusive, Compassionate, and High-Quality Healthcare for Transgender Individuals
In this episode for all healthcare professionals and any patient-facing clinical staff, Nelson F. Sanchez, MD, shares key insights on the need for equitable…
Decera Clinical Education Oncology PodcastInclusive Healthcare for Transgender Individuals: Insights From a Healthcare Professional’s Transition Experience
In this episode, Pharmacist Olivia Buckoski shares her experience undergoing medical and social transition and offers advice from the perspective of both a…
Decera Clinical Education Oncology PodcastAnti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials
In this episode, Jyoti D. Patel, MD, and Ani Balmanoukian, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoint…
Decera Clinical Education Oncology PodcastTargeting TIGIT: Understanding New Approaches for Inhibiting the Immune Checkpoint Pathway
In this episode, Jyoti D. Patel, MD, and Diwakar Davar, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoint target…
Decera Clinical Education Oncology PodcastEvolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer
In this episode, Nilofer S. Azad, MD, and Kanwal Raghav, MD, discuss current and emerging uses of regorafenib and TAS-102 in later-line treatment of patients…
Decera Clinical Education Oncology PodcastExpert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL
In this episode, Jeff P. Sharman, MD; Matthew S. Davids, MD, MMSc; and Anthony Mato, MD, MSCE, answer questions from a live CCO webinar on current best…
Decera Clinical Education Oncology PodcastExpert Insights on Optimal Current Management of Patients With Cholangiocarcinoma
In this episode, Lipika Goyal, MD, leads an engaging discussion with Christine Chio, PharmD, BCOP, and Caroline Kuhlman, NP, on current treatment of patients…
Decera Clinical Education Oncology PodcastCancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes
In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, including Treatment for MDS…
Decera Clinical Education Oncology PodcastExpert Insights on Targeted Therapies for Advanced Systemic Mastocytosis
In this episode, Dr Prithviraj Bose, Pharmacist Caitlin R. Rausch, and Nurse Practitioner Ilene A. Galinsky discuss incorporating KIT-targeted therapies into…
Decera Clinical Education Oncology PodcastAdvances in B-Cell Lymphomas: Understanding Current Treatment Approaches
In this episode, Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, discuss treatment approaches for patients with B-cell lymphomas, including…
Decera Clinical Education Oncology PodcastTKIs for Advanced HCC in the Second Line and Beyond
In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss second line treatment of…
Decera Clinical Education Oncology PodcastNew Directions With PARP Inhibitors in Pancreatic Cancer
In this episode, Eileen M. O’Reilly, MD, and Naureen Starling, MD, FRCP, discuss emerging therapeutic strategies involving PARP inhibitor therapy in the…
Decera Clinical Education Oncology PodcastEvolving Therapy for Myeloma: Experts Discuss Patient Case Examples
In this episode,Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discuss treatment…
Decera Clinical Education Oncology PodcastExpert Insights on Advances in Immune Thrombocytopenia
In this episode, Keith R. McCrae, MD; Nichola Cooper, MD; and Rachael Grace, MD, MMSc,provide expert insights on immune thrombocytopenia management, along with…
Decera Clinical Education Oncology PodcastPrecision Medicine for aTTP: Expert Answers to Your Questions
In this episode, Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshal Mazepa, MD, answer questions from an audience of healthcare professionals on topics related…
Decera Clinical Education Oncology PodcastPrecision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions
In this episode, Steven M. Horwitz, MD; Francine Foss, MD; and Barbara Pro, MD, answer questions from an audience of healthcare professionals on topics related…
Decera Clinical Education Oncology PodcastMultidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease
In this podcast episode, Conor Ernst Steuer, MD, a medical oncologist; Frank Schneider, MD, a pathologist; and Elise Hitron, MSN, FNP-C, a phase I clinical…
Decera Clinical Education Oncology PodcastExperts Answer Questions on Current and Emerging Options for Hemophilia A Management
In this podcast episode, 3 experts answers questions on the management of hemophilia A from a live webinar. Topics include: Which patients should have…
Decera Clinical Education Oncology PodcastInduction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations…
Decera Clinical Education Oncology PodcastStrategies for Secondary AML and Emerging Therapies for AML
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials…
Decera Clinical Education Oncology PodcastTargeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses targeted therapy with FLT3 and IDH1/2 inhibitors in AML, with a focus on the nursing…
Decera Clinical Education Oncology PodcastAn Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses acute myeloid leukemia and management approaches for patients unfit for intensive…
Decera Clinical Education Oncology PodcastManaging Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications
In this podcast episode,Sarah Tinsley, PhD, APRN, AOCN, discusses management strategies for higher-risk and relapsed/refractory (R/R) myelodysplastic syndromes…
Decera Clinical Education Oncology PodcastManaging Lower-Risk Myelodysplastic Syndrome: Nursing Implications
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses management strategies for lower-risk myelodysplastic syndrome (MDS) with a focus on…
Decera Clinical Education Oncology PodcastKey Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer
In this episode, Chiara Cremolini, MD, PhD, and Teresa Macarulla, MD, PhD, discuss the clinical data that inform how they select regorafenib and TAS-102 as…
Decera Clinical Education Oncology PodcastThe Evolving Role of TKIs in First-line Treatment of Advanced HCC
In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss first-line treatment of…
Decera Clinical Education Oncology PodcastExpert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers
In this episode, Nicole Concin, MD, PhD, highlights key data for endometrial and ovarian cancers presented at the ESGO 2021 annual meeting, including: Pooled…
Decera Clinical Education Oncology PodcastExperts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer
In this podcast episode, Julie Brahmer, MD, MSc, and Jarushka Naidoo, MB BCH BAO, MHS, answer audience questions from a live CCO webinar on evolving…
Decera Clinical Education Oncology PodcastOvercoming Acquired Resistance With Second-Generation TRK Inhibitors
In this podcast episode, George D. Demetri, MD, and Alexander Drilon, MD, discuss emerging data on the efficacy, safety, and clinical role of second-generation…
Decera Clinical Education Oncology PodcastRole of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma
In this podcast episode, Jean-Yves Blay, MD, PhD, and Robin L. Jones, BSc, MBBS, MRCP, MD(Res), discuss the most important clinical trial data on leveraging…